Global experience in Reproductive Management: Lessons learned

This intends to highlight our experiences across various markets, including South America, New Zealand, and Austrailia. A point of regular interest has been competitors inquiries about the P4 levels in our devices and how this aspect has contributed to increasing our sales in these regions. 

It also intends to educate around synchronisation and FTAI protocols, use of sexed semen, differing levels of progesterone in intravaginal devices on the market and how this affects fertility, use of eCG in fertility protocols, experience of Syntex in fertility markets in New Zealand, Austrailia and South America.